# DESCRIPTION

- claim benefit of prior application

## FIELD

- relate to detecting biomarkers for biliary tract cancer

## BACKGROUND

- describe biliary tract cancer and its diagnosis
- discuss limitations of current diagnostic methods

## SUMMARY

- describe methods for detecting biomarkers for biliary tract cancer

## DETAILED DESCRIPTION

- describe method of detecting abnormal biomarker associated with biliary tract cancer
- detail biomarker characteristics and detection methods
- outline various embodiments of the invention

### EXAMPLES

- introduce patient and blood sample preparation
- describe serum pretreatment and mass spectrometry methods
- detail protein identification and statistical analysis
- present results of MALDI-TOF-MS analysis
- analyze diagnostic accuracy of CA19-9, CEA, and 4204 Da peptide
- identify 4204 Da peptide as a fragment of prothrombin
- discuss significance of findings and potential clinical applications
- conclude with implications for diagnosis and treatment of biliary tract cancer

